Correlation Between Marketwise and MoonLake Immunotherapeuti

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Marketwise and MoonLake Immunotherapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marketwise and MoonLake Immunotherapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marketwise and MoonLake Immunotherapeutics, you can compare the effects of market volatilities on Marketwise and MoonLake Immunotherapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marketwise with a short position of MoonLake Immunotherapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marketwise and MoonLake Immunotherapeuti.

Diversification Opportunities for Marketwise and MoonLake Immunotherapeuti

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Marketwise and MoonLake is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Marketwise and MoonLake Immunotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MoonLake Immunotherapeuti and Marketwise is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marketwise are associated (or correlated) with MoonLake Immunotherapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MoonLake Immunotherapeuti has no effect on the direction of Marketwise i.e., Marketwise and MoonLake Immunotherapeuti go up and down completely randomly.

Pair Corralation between Marketwise and MoonLake Immunotherapeuti

Given the investment horizon of 90 days Marketwise is expected to under-perform the MoonLake Immunotherapeuti. In addition to that, Marketwise is 1.81 times more volatile than MoonLake Immunotherapeutics. It trades about -0.04 of its total potential returns per unit of risk. MoonLake Immunotherapeutics is currently generating about 0.23 per unit of volatility. If you would invest  4,670  in MoonLake Immunotherapeutics on August 26, 2024 and sell it today you would earn a total of  762.00  from holding MoonLake Immunotherapeutics or generate 16.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Marketwise  vs.  MoonLake Immunotherapeutics

 Performance 
       Timeline  
Marketwise 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Marketwise has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
MoonLake Immunotherapeuti 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MoonLake Immunotherapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, MoonLake Immunotherapeuti showed solid returns over the last few months and may actually be approaching a breakup point.

Marketwise and MoonLake Immunotherapeuti Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Marketwise and MoonLake Immunotherapeuti

The main advantage of trading using opposite Marketwise and MoonLake Immunotherapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marketwise position performs unexpectedly, MoonLake Immunotherapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MoonLake Immunotherapeuti will offset losses from the drop in MoonLake Immunotherapeuti's long position.
The idea behind Marketwise and MoonLake Immunotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges